Shintani Hideharu,
Department of Chemistry Chuo University, Japan
Ji li,
Department of Pharmacology and Toxicology State University of New York, USA
Journal of Pharmaceutical Regulatory Affairs represents one of the leading International online platforms for communication and exchange of scholarly information on the current and prevailing laws and the regulatory concepts as applicable to the development and commercialization of pharmaceutical & biomedical products; food; beverages; biotech products and cosmetics originating from across the world.
The journal publishes peer-reviewed articles under open access creative commons attribution license terms and are of immense relevance to the pharmacy students, physicians, clinicians, pharmaceutical & biopharmaceutical industrialists, regulatory affair professionals, manufacturers of medical devices and equipment, practicing attorneys, regulators, as well as academic and research community engaged in the designing and development of new drugs.
The journal offers wide coverage of topics including trends and guidelines of various National and International regulatory agencies, Pharmacovigilance, new drug application processes, protocols of achieving regulatory compliance, legislative revisions, regulatory approvals, marketing practices, as well as the formulation & streamlining of good manufacturing practice. The journal’s core focus is on the procedures, protocols, standards & policies, pharmaceutical regulations, quality control and quality assurance of drug development.
Articles published in Pharmaceutical Regulatory Affairs: Open Access have been cited by esteemed scholars and scientists all around the world. Pharmaceutical Regulatory Affairs: Open Access has got h-index 9 , which means every article in Pharmaceutical Regulatory Affairs: Open Access has got 9 average citations.
Pharmaceutical Regulatory Affairs: Open Access received 400 citations as per Google Scholar report
